+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Type 2 Diabetes Drug"

Type 2 Diabetes Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Type 2 Diabetes Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 185 Pages
  • Global
From
Type 2 Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Type 2 Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Drug Pipelines
  • September 2026
  • 150 Pages
  • Global
From
Type 2 Diabetes Drugs and Devices Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Distribution Channel - Product Thumbnail Image

Type 2 Diabetes Drugs and Devices Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Distribution Channel

  • Report
  • July 2026
  • 160 Pages
  • Global
From
GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 - Product Thumbnail Image

GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033

  • Report
  • October 2025
  • 456 Pages
  • Global
From
Non-Peptide Small Molecule Glucagon-Like Peptide (GLP)-1 Multi-Indication Pipeline Market Global Report 2026 - Product Thumbnail Image

Non-Peptide Small Molecule Glucagon-Like Peptide (GLP)-1 Multi-Indication Pipeline Market Global Report 2026

  • Report
  • April 2026
  • 250 Pages
  • Global
From
Semaglutide Market Report by Product, Application, Distribution Channel, Countries and Companies Analysis 2026-2034 - Product Thumbnail Image

Semaglutide Market Report by Product, Application, Distribution Channel, Countries and Companies Analysis 2026-2034

  • Report
  • June 2026
  • 200 Pages
  • Global
From
Sitagliptin Metformin Extended Release Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Sitagliptin Metformin Extended Release Tablets Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Sulfonylureas - Global Strategic Business Report - Product Thumbnail Image

Sulfonylureas - Global Strategic Business Report

  • Report
  • September 2026
  • 362 Pages
  • Global
From
Diabetes Drugs - Global Strategic Business Report - Product Thumbnail Image

Diabetes Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 478 Pages
  • Global
From
Liraglutide Market Report 2026 - Product Thumbnail Image

Liraglutide Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2026 - Product Thumbnail Image

Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Type 2 Diabetes Mellitus Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Type 2 Diabetes Mellitus Treatment Market - Global Strategic Business Report

  • Report
  • September 2026
  • 381 Pages
  • Global
From
Type 2 Diabetes - Competitive Landscape and Clinical Trial Analysis, 2026 - Product Thumbnail Image

Type 2 Diabetes - Competitive Landscape and Clinical Trial Analysis, 2026

  • Report
  • September 2026
  • 450 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 280 Pages
  • Global
From
Type 2 Diabetes Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Type 2 Diabetes Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 110 Pages
  • Global
From
Type 2 Diabetes Mellitus Treatment Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035) - Product Thumbnail Image

Type 2 Diabetes Mellitus Treatment Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • May 2026
  • 400 Pages
  • Global
From
Human Insulin Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Human Insulin Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • December 2025
  • 150 Pages
  • Global
From
North America Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

North America Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 150 Pages
  • North America
From
Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025 - Product Thumbnail Image

Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025

  • Report
  • August 2020
  • 250 Pages
  • Saudi Arabia
From
Teneligliptin Hydrobromide API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Teneligliptin Hydrobromide API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Loading Indicator

The Type 2 Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat Type 2 Diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin properly. Type 2 Diabetes Drugs are used to help control blood sugar levels, reduce the risk of complications, and improve overall health. These drugs can be taken orally, injected, or inhaled. Common Type 2 Diabetes Drugs include Metformin, Sulfonylureas, Thiazolidinediones, Meglitinides, DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors. Some companies in the Type 2 Diabetes Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Boehringer Ingelheim, and Takeda. Show Less Read more